Worenine attenuates pulmonary fibrosis potentially through modulation of PBK/SRC-associated TGF-β1/Smad and NF-κB signaling pathways.
Worenine attenuates experimental pulmonary fibrosis, potentially through modulation of PBK/SRC-associated signaling and the TGF-β1/Smad, ERK, and NF-κB pathways, and provide a rationale for further investigation of Worenine as a potential therapeutic candidate for PF.